Quick Answer
RxSight, Inc. reported Total Revenue of $134.48 million for fiscal year 2025.
RxSight, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $134.48M | -3.9% |
| 2024 | $139.93M | +57.1% |
| 2023 | $89.08M | +81.8% |
| 2022 | $49.01M | +116.9% |
| 2021 | $22.59M | +53.9% |
| 2020 | $14.68M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $30.34M | -14.1% | -9.8% |
| June 30, 2025 | $33.64M | -3.6% | -11.2% |
| March 31, 2025 | $37.90M | +28.4% | +7.3% |
| September 30, 2024 | $35.31M | +59.1% | +1.2% |
| June 30, 2024 | $34.89M | +67.6% | +18.2% |
| March 31, 2024 | $29.51M | +68.7% | +32.9% |
| September 30, 2023 | $22.20M | +76.0% | +6.7% |
| June 30, 2023 | $20.81M | +83.2% | +19.0% |
- RxSight, Inc. showed a decrease of -3.9% in Total Revenue compared to the prior fiscal year.
- Over the 2020–2025 period, RxSight, Inc.’s total revenue has grown by 816.2% (from $14.68 million to $134.48 million).
- The most recent figure is from RxSight, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: